about
Interventions to prevent steroid-induced osteoporosis and osteoporotic fractures in Duchenne muscular dystrophyLow bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment.Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity.Driven to death: Inhibition of farnesylation increases Ras activity and promotes growth arrest and cell death [corrected]Fractures in myelomeningocele.Updated recommendations for the diagnosis and management of osteoporosis: a local perspectiveThe Effect of Osteoporosis Treatments on Fatigue Properties of Cortical Bone Tissue.Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role.Crystal structure of bis-[(1-ammonio-1-phosphono-eth-yl)phospho-nato]tetra-aqua-cadmium dihydrate: a powder X-ray diffraction studySystematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritisBisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series.Skeletal imaging effects of pamidronate therapy in osteosarcoma patients.Can bisphosphonates play a role in the treatment of children with chronic kidney disease?The use of bisphosphonates in children: review of the literature and guidelines for dental management.Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to McCune-Albright Syndrome in a Child: A Case Report.Bisphosphonate-related osteonecrosis of the jaw: the Florence experience.Effectiveness of the treatment with intravenous pamidronate in children with rheumatic diseases.Safety and efficacy of intravenous zoledronic acid in paediatric osteoporosis.Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy.
P2860
Q24198280-ED0A8743-68FE-4F18-AAFB-5E148C63BAFEQ33574569-BA52BBED-AE5B-4A79-A1C6-7C113FC80D18Q33665130-3581C4F8-E3BF-461A-99D4-891D242D5706Q33843725-7FD19E83-A421-445D-9AA6-7007C18796C4Q34166648-5EBA6845-DAFF-4BBC-83AA-124230071A3FQ35008617-ADDD3523-E88B-4DBE-A3C7-C3BF5208EEF3Q35012189-52090577-DBA9-4015-8F60-43E041A65DB8Q35605709-CA6F10DB-2667-4CD5-86D8-A534B24C526CQ35628070-BD956C2D-8EAD-4123-893E-B0B3CBABC3DCQ36153306-6F631E19-68C4-4D76-9716-1F8C80A0B69AQ37055377-8AF7675E-CD21-45C3-8730-A0D9596497A5Q37807268-A34A4BB5-E862-4480-981F-E9DC1531003BQ37832414-1CABF749-B7B5-4817-9C26-EDA47C0D3A77Q38185138-32910918-1651-4BDD-BCCC-FC2B66C13894Q38766431-BDEA20FE-52B7-4895-94F1-3C3D0067A43BQ41876156-8C67CC83-A261-48BC-BDFE-6CC309F645ACQ42210395-78E3B654-8082-441F-93F8-2727DA22392CQ45744445-38B78CF4-31B6-4C74-836F-A0964324FBC7Q46062739-CE34AA55-2F81-4CA8-BE98-A93BDF58995FQ46790362-9721571C-D0B3-4E36-BC56-DA846825A719Q51873934-280EA7BF-DAE4-4C58-BA14-4FF6FFED5A63
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Bisphosphonate treatment of bone disease
@ast
Bisphosphonate treatment of bone disease
@en
type
label
Bisphosphonate treatment of bone disease
@ast
Bisphosphonate treatment of bone disease
@en
prefLabel
Bisphosphonate treatment of bone disease
@ast
Bisphosphonate treatment of bone disease
@en
P2860
P356
P1476
Bisphosphonate treatment of bone disease
@en
P2093
P2860
P304
P356
10.1136/ADC.2003.036590
P407
P577
2005-05-01T00:00:00Z